News

Jeff Todd, president and CEO of Prevent Blindness, and Donna Fishman, Director of the National Center for Children’s Vision and Eye Health at Prevent Blindness, join David Hutton of Ophthalmology Times to discuss the report.

The investigators undertook a study in which they retrospectively evaluated the presence and amount of small HRF in the eyes of patients with different macular atrophic phenotypes.

In a study, a team of UCLA investigators detail a deep-learning model pre-trained on 2D scans that accurately predicts disease-risk factors from 3D medical-scan modalities.

This Week in Ophthalmology is a video series highlighting some of the top articles featured on the Ophthalmology Times website.

The research findings highlighted a new therapeutic avenue in ocular and neurodegenerative disease

In a study, a team of UCLA investigators detail a deep-learning model pre-trained on 2D scans that accurately predicts disease-risk factors from 3D medical-scan modalities.

Investigators studied global-flash multifocal electroretinogram responses

The donation will support the development of the Artificial Intelligence Innovation Center, a collaborative hub with a focus of preserving the vision of patients with various eye conditions and eliminating blindness.

The resubmission comes after receiving a Complete Response Letter at the end of 2023.

The award from the National Institutes of Health will enable a team of researchers to investigate Alzheimer and Parkinson progression through the eye.

A different approach better serves patients with diabetic retinopathy

Ciclosporin 0.1% eye drops solution will be marketed under the brand name Vevizye in the EU for the treatment of dry eye disease.

Current and future options for Fuchs endothelial corneal dystrophy

Gene therapy was a major topic at the 2024 EURETINA and Retina Society meetings

Because the inner retinal function is thought to affect the emmetropization process, authors suggested that caffeine may be involved in ocular growth

The company’s flagship product is Reti-CVD, an AI diagnostic solution that autonomously assesses future cardiovascular disease risk using a retina scan.

The e-poster came in 2nd place for the August Deutman award at the EURETINA Congress

The TECNIS Odyssey IOL is a new full vision range IOL built on the TECNIS platform.

Ali Erginay, MD, spoke about the important developments in retinal imaging, specifically the Red-Blue-Green (RGB) imaging modalities during his interview with Ophthalmology Times Europe, which took place at the EURETINA 2024 meeting held in Barcelona, Spain, on September 19-22, 2024.

Dr Yorston delivered the Gisbert Richard Lecture at this year's EURETINA Congress

The retina space continues to see new advancements and clinical trial results, many of which are shared at industry conferences throughout the year.

David Eichenbaum, MD, spoke with Modern Retina to provide and overview on his presentation at ASRS 2024 and the current state of geographic atrophy treatment.

Dilsher Dhoot, MD, sat down with Modern Retina to provide some insights on the phase 1 HELIOS trial, which he presented on during the 2024 ASRS meeting held in Stockholm, Sweden earlier in 2024.

Clobetasol is FDA-approved for the treatment of post-operative inflammation and pain following ocular surgery.

Digital exclusive article on red-blue-green ultrawidefield (UWF) imaging

Published data from a pair of Phase 3 clinical trials demonstrated a reversal of pharmacologically-induced mydriasis with a favorable safety profile.